You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TNF

Showing 1 - 25 of 6,796
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive

Recruiting
  • Drug Monitoring
  • Inflammatory Bowel Diseases
  • Tumor necrosis factor (TNF)-alpha inhibitors
  • Valladolid, Spain
    Hospital Universitario Rio Hortega
Aug 8, 2023

Sarcoidosis Trial (STOP arm)

Not yet recruiting
  • Sarcoidosis
  • STOP arm
  • (no location specified)
Jan 16, 2023

Melanoma Trial in Toulouse (Nivolumab+Ipilimumab in combination with Anti TNF-a Certolizumab, Nivolumab+Ipilimumab in

Active, not recruiting
  • Melanoma
  • Nivolumab+Ipilimumab in combination with Anti TNF-α Certolizumab
  • Nivolumab+Ipilimumab in combination with Anti TNF-α Infliximab
  • Toulouse, France
    Institut Claudius Regaud IUCT-ONCOPOLE
Nov 18, 2022

Benign Prostatic Hyperplasia (BPH) Trial in Glenview (Adalimumab)

Not yet recruiting
  • Benign Prostatic Hyperplasia (BPH)
  • Glenview, Illinois
    NorthShore University HealthSystem
Sep 25, 2023

Pneumococcal Vaccination in Patients With Anti-TNF Alpha Therapy

Not yet recruiting
  • Pneumococcal Vaccine
  • Pneumococcal vaccine
  • Pontoise, France
    Internal Medicine Department - NOVO Hospital - Pontoise site
Mar 28, 2023

Ulcerative Colitis Trial (Appendectomy, Infliximab)

Not yet recruiting
  • Ulcerative Colitis
  • (no location specified)
Jun 27, 2023

Nasopharyngeal Carcinoma, TNF, Chemo-radiotherapy Trial (5-fu, Cisplatin, Radiotherapy)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +2 more
  • (no location specified)
Jun 22, 2022

Blocking TNF to Potentiate ICI-dependent Immune Awakening in

Recruiting
  • Melanoma
  • +2 more
    • Toulouse, France
      Institut Claudius Regaud
    May 25, 2023

    Psoriatic Arthritis Trial in Philadelphia (Guselkumab, Golimumab, Placebo)

    Not yet recruiting
    • Psoriatic Arthritis
    • Philadelphia, Pennsylvania
      Hospital at the University of Pennsylvania
    Dec 20, 2022

    Lung Transplant; Complications Trial in Chicago (Etanercept Injection [Enbrel])

    Enrolling by invitation
    • Lung Transplant; Complications
    • Etanercept Injection [Enbrel]
    • Chicago, Illinois
      Northwestern University
    Jul 10, 2023

    Psoriatic Arthritis Trial in Philadelphia (Guselkumab, Golimumab)

    Not yet recruiting
    • Psoriatic Arthritis
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Nov 18, 2022

    Solid Tumor Trial (Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T), Tumor necrosis factor-thymosin alfa 1 recombinant

    Completed
    • Solid Tumor
    • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)
    • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy
    • (no location specified)
    Jun 8, 2023

    Crohn's Disease, Inflammatory Bowel Disease, Ulcerative Colitis Trial in Madrid (Anti-TNF: Infliximab (Infusion), Anti-TNF

    Active, not recruiting
    • Crohn's Disease
    • +2 more
    • Anti-TNF: Infliximab (Infusion)
    • +2 more
    • Madrid, Spain
      Hospital Universitario de La Princesa
    Mar 15, 2022

    Hidradenitis Suppurativa Trial (Upadacitinib, Placebo)

    Not yet recruiting
    • Hidradenitis Suppurativa
    • (no location specified)
    May 26, 2023

    Janus Kinase Inhibitors Vs Tumor Necrosis Factor Inhibitors in

    Not yet recruiting
    • Rheumatoid Arthritis
    • Observation
    • (no location specified)
    Oct 8, 2022

    Recurrent Unexplained Implantation Failure Trial (Certolizumab (CIMZIA® ; TNF-a antagonist), Placebo (NaCl 0.9 % solution))

    Not yet recruiting
    • Recurrent Unexplained Implantation Failure
    • Certolizumab (CIMZIA® ; TNF-α antagonist)
    • Placebo (NaCl 0.9 % solution)
    • (no location specified)
    Jun 30, 2023

    Tuberculous Meningitis, HIV I Infection Trial in Rio De Janeiro, Maputo, Lusaka (Adalimumab Injection)

    Not yet recruiting
    • Tuberculous Meningitis
    • HIV I Infection
    • Adalimumab Injection
    • Rio De Janeiro, Brazil
    • +2 more
    Jan 31, 2023

    Glioblastoma Trial in Zürich (L19TNF, Lomustine)

    Recruiting
    • Glioblastoma
    • Zürich, Switzerland
      Universitatspital Zurich - Klinik fur Neurologie & Hirntumorzent
    Apr 19, 2022

    Crohn's Disease, Ulcerative Colitis Trial in Montpellier (Immuno monitoring)

    Completed
    • Crohn's Disease
    • Ulcerative Colitis
    • Immuno monitoring
    • Montpellier, France
      University hospital
    Dec 13, 2022

    Tumor Necrosis Factor-alpha Antagonists in Rheumatoid Arthritis.

    Recruiting
    • Rheumatoid Arthritis
    • +2 more
    • Infliximab: Adalimumab; Etanercept;
    • Sulaymaniyah, Kurdistan Region, Iraq
      Hiwa Khidhir Saaed
    May 12, 2022

    Rheumatoid Arthritis Trial in Montpellier (Abatacept (M3-M12), TNF Inhibitor (M3-M12), TNF Inhibitor (M0-M3))

    Not yet recruiting
    • Rheumatoid Arthritis
    • Abatacept (M3-M12)
    • +2 more
    • Montpellier, France
      Centre Hospitalier Universitaire de Montpellier
    Jun 16, 2022

    Failure to Thrive, Infection, Bacterial, Growth Faltering Trial in Surabaya (high calorie formula (oral nutritional

    Recruiting
    • Failure to Thrive
    • +2 more
    • high calorie formula (oral nutritional supplement/ONS)
    • Surabaya, East Java, Indonesia
      Husada Utama Hospital
    Oct 2, 2022

    Intercellular Adhesion Molecule-1 and TNF-a in COVID-19

    Completed
    • COVID-19
    • Cytokine Storm
      • Banhā, Kalyobia, Egypt
        Benha University hospital
      Jun 10, 2022

      Periodontitis Trial in Rize (biochemical analysis)

      Completed
      • Periodontitis
      • biochemical analysis
      • Rize, Turkey
        Recep Tayyip Erdogan University
      Oct 18, 2023

      Type 1 Diabetes Trial in La Jolla, Seattle (Etanercept, Vedolizumab)

      Recruiting
      • Type 1 Diabetes
      • La Jolla, California
      • +1 more
      Jul 21, 2022